Type 2 Diabetes: Clinical Trials

17 trials for Type 2 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 recruiting, 1 active not recruiting, 1 withdrawn. 17 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 117Completed 10, Recruiting 5, Active not recruiting 1, Withdrawn 1

Follow Type 2 Diabetes: new trials by email Literature Review of Type 2 Diabetes trials Research Report on Type 2 Diabetes

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
Montelukast, Montelukast Placebo - Type 2 Diabetes
Early Phase 1RecruitingUniversity of Colorado, Denver502026-10-122026-10-06
SGLT2i, Hepatic Glucose Production, and SNS
Empagliflozin 25 MG - Type 2 Diabetes
Early Phase 1RecruitingThe University of Texas Health Science Center at San Antonio222025-01-072026-07-17
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
Oral sodium suppression test, Saline suppression test, Captopril suppression test - Type 2 Diabetes, Chronic Kidney Diseases
Early Phase 1Active not recruitingBrigham and Women's Hospital1252024-05-152026-08-13
Precision Dosing of Metformin in Youth With T2D
Metformin - Type 2 Diabetes
Early Phase 1RecruitingUniversity of California, San Francisco202024-04-252025-12-23
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
Ketone Monoester (KE) - Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction
Early Phase 1RecruitingThe University of Texas Health Science Center at San Antonio102024-01-162026-01-21
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Trehalose, Placebo - Type 2 Diabetes, Healthy Aging
Early Phase 1RecruitingMedical College of Wisconsin602023-01-012025-10-30
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
REMD-477, Placebo Subcutaneous injection - Type 2 Diabetes, Glucose Tolerance Impaired
Early Phase 1CompletedThe University of Texas Health Science Center at San Antonio42021-11-102024-08-09
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Ertugliflozin - Cardiovascular Diseases, Atherosclerosis
Early Phase 1CompletedStanford University612020-07-012026-06-04
Liver-enriched Antimicrobial Peptide 2
Liver-enriched antimicrobial peptide 2, Placebo - Type 2 Diabetes
Early Phase 1CompletedUniversity Hospital, Gentofte, Copenhagen102019-01-282021-05-26
Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus
Sitagliptin - Type 2 Diabetes
Early Phase 1WithdrawnUniversity of Missouri-Columbia2015-05-012017-06-01
Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes
LEHEL multi-nutrients supplement - Type 2 Diabetes
Early Phase 1CompletedShaoguan University712013-06-012014-05-12
Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin
NM504 - Type 2 Diabetes
Early Phase 1CompletedNuMe Health102013-05-012014-07-24
Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients
Lactobacillus reuteri DSM 17938 - Type 2 Diabetes, Insulin Resistance
Early Phase 1CompletedVastra Gotaland Region122012-05-012020-02-12
Self-management in Type 2 Diabetes Patients Using the Few Touch Application
Use of Few Touch Application (FTA), Use of FTA and health counseling based on TTM and CBT - Type 2 Diabetes
Early Phase 1CompletedUniversity Hospital of North Norway1512011-03-012014-12-12
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
euinsulinemic euglycemic glucose clamp, euinsulinemic hyperglycemic glucose clamp, Hyperinsulinemic euglycemic glucose clamp - Type 2 Diabetes
Early Phase 1CompletedUniversity of Maryland, Baltimore312009-07-012019-09-12
Antioxidant Treatment of Type 2 Diabetes
Placebo, n-aceylcysteine - Type 2 Diabetes
Early Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)442008-07-012014-12-24
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
Hyperinsulinemic Hypoglycemic Clamp - Type 2 Diabetes
Early Phase 1CompletedUniversity of Maryland, Baltimore202007-05-012019-09-12

Narrower conditions

Diabetes Mellitus, Type 2 (17)  ·  Diabetes Mellitus (3)  ·  Insulin Resistance (3)  ·  Atherosclerosis (1)  ·  Bone Diseases, Metabolic (1)  ·  Cardiovascular Diseases (1)  ·  Glucose Intolerance (1)  ·  Heart Failure, Systolic (1)  ·  Hypoglycemia (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Metabolic Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Endocrine System Diseases (17)  ·  Glucose Metabolism Disorders (17)  ·  Nutritional and Metabolic Diseases (17)  ·  Metabolic Diseases (16)  ·  Diabetes Mellitus (14)  ·  Hyperinsulinism (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Bone Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)

Interventions

Metformin (1)  ·  Sitagliptin Phosphate (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  Trehalose (1)  ·  empagliflozin (1)  ·  ertugliflozin (1)  ·  montelukast (1)  ·  rVSV-deltaG-spike COVID-19 vaccine (1)  ·  soybean oil, phospholipid emulsion (1)  ·  volagidemab (1)

Sponsors

The University of Texas Health Science Center at San Antonio (3)  ·  University of Maryland, Baltimore (2)  ·  Brigham and Women's Hospital (1)  ·  Medical College of Wisconsin (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  NuMe Health (1)  ·  Shaoguan University (1)  ·  Stanford University (1)  ·  University Hospital of North Norway (1)  ·  University Hospital, Gentofte, Copenhagen (1)  ·  University of California, San Francisco (1)  ·  University of Colorado, Denver (1)  ·  University of Missouri-Columbia (1)  ·  Vastra Gotaland Region (1)

Countries

United States (13)  ·  China (1)  ·  Denmark (1)  ·  Norway (1)  ·  Sweden (1)

Top investigators

Ralph DeFronzo, MD (2)  ·  Stephen N. Davis, MD (2)  ·  Carolina Solis-Herrera, MD (1)  ·  Filip K Knop, MD, PhD (1)  ·  Muhammed T Sarmini, MD (1)  ·  Shylaja Srinivasan, MD (1)  ·  Tracey McLaughlin, MD (1)  ·  Wenhua Ling, Ph.D. (1)  ·  William Hughes, Ph.D. (1)

Results publications

PMID 20587723, PMID 23978690, PMID 25695946, PMID 27239317, PMID 29784635, PMID 31492176

NIH funding

1UM1TR004538-01 (1), K23DK120932 (1), R01DK024092 (1)